Lipokinetic studies with gemfibrozil (CI-719)

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):94-7.

Abstract

Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and in patients with endogenous hypertriglyceridaemia. We have confirmed these findings.

MeSH terms

  • Apoproteins / metabolism
  • Fatty Acids, Nonesterified / metabolism
  • Humans
  • Hypolipidemic Agents / pharmacology*
  • Kinetics
  • Lipid Metabolism*
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, VLDL / metabolism
  • Time Factors
  • Triglycerides / blood
  • Valerates / pharmacology*
  • Xylenes / pharmacology*

Substances

  • Apoproteins
  • Fatty Acids, Nonesterified
  • Hypolipidemic Agents
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Triglycerides
  • Valerates
  • Xylenes